| 0 (0%) | 11-11 17:47 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 141.84  |
1-year : | 165.67 |
| Resists | First : | 121.44 |
Second : | 141.84 |
| Pivot price | 117.51  |
|||
| Supports | First : | 115.73 |
Second : | 112.19 |
| MAs | MA(5) : | 115.92 |
MA(20) : | 117.45 |
| MA(100) : | 114.03 |
MA(250) : | 108.33 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 35.5 |
D(3) : | 22.4 |
| RSI | RSI(14): 51.1 |
|||
| 52-week | High : | 121.79 | Low : | 81.43 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ RZV ] has closed above bottom band by 49.5%. Bollinger Bands are 1.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 117.64 - 118.09 | 118.09 - 118.55 |
| Low: | 115.97 - 116.53 | 116.53 - 117.08 |
| Close: | 116.6 - 117.44 | 117.44 - 118.28 |
Tue, 11 Nov 2025
How RZV stock trades pre earnings - Weekly Volume Report & Weekly High Conviction Ideas - newser.com
Sat, 08 Nov 2025
(RZV) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Sat, 18 Oct 2025
Recombinant Herpes Zoster Vaccine Is Effective at Reducing Shingles - Vax-Before-Travel
Tue, 14 Oct 2025
Data: Two doses of recombinant shingles vaccine effective, even in those who received live vaccine - CIDRAP
Mon, 13 Oct 2025
Recombinant zoster vaccine may be effective in older adults, including the immunocompromised - 2 Minute Medicine
Mon, 22 Sep 2025
Real-World Evidence Shows RZV Prevents HZ in Adults With Autoimmune Diseases - Vaccine Advisor
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|